Long-term trajectories of positive and negative symptoms in first episode psychosis: A 10 year follow-up study in the OPUS cohort
Introduction
The investigation of long-term outcomes is a key focus within schizophrenia research. Information on long term prognosis can assist in the identification of factors that could impact on illness course. While it has been previously proposed that the typical course of illness in schizophrenia is chronic and deteriorating (Davidson and McGlashan, 1997), recent studies have indicated that a heterogeneous course of illness is most characteristic, with a significant number of people achieving symptom remission and recovery (Van Os and Kapur, 2009, Henry et al., 2010a, Harrow et al., 2005, Wunderink et al., 2009).
Traditionally, long-term outcomes in schizophrenia have been assessed by investigating the rates of symptom remission and recovery at a specified time after diagnosis (Menezes et al., 2006). While these studies provide valuable cross sectional information about levels of psychopathology and functioning for people with schizophrenia, they do not provide detailed information about how the illness is manifested over time. Studies using longitudinal data can contribute to a better understanding of the course of illness and help clinicians to adjust the timing and intensity of interventions to optimize treatment outcomes for people with schizophrenia.
The classification of outcomes into dichotomous categories such as recovered or not and symptom remission or not, is commonplace within schizophrenia research but this practice can also be problematic. If dichotomization is undertaken without evidence of a bimodal distribution, this may lead to the inefficient analysis of continuous data, where up to one third of the data from the sample is thrown away (Streiner, 2002, Royston et al., 2006). Furthermore, cut-off scores for membership into a particular category are often arbitrary in nature (Mulder et al., 2003). The oversimplification of complex outcomes into categories such as recovered/not recovered can create difficulties in the translation of results into clinically meaning information (Rietschel et al., 1999).
Advances in statistical modeling techniques have meant that it is now possible to identify categories based on temporal patterns of change using latent class models (LCA) and growth mixture modeling (GMM) (Beunckens et al., 2008). The advantage of these methods is that the subpopulations and thresholds do not need to be defined or identified arbitrarily. Furthermore, LCA and GMM are sensitive to the pattern of change over time and are robust in the presence of missing data (Muthen et al., 2002, Muthen and Brown, 2009).
Recently, a number of studies have used LCA or similar growth mixture models to identify different trajectories to treatment response within schizophrenia. Rabinowitz and colleagues identified three response trajectories within a cohort of people with schizophrenia over a period of ten years. A significant majority showed improvement and stabilization in positive symptoms (Rabinowitz et al., 2007). Levine et al. (2011) identified five distinct illness trajectories, where the typical course was one of initial deterioration followed by progressive amelioration (Levine et al., 2011). A limitation of both these studies was the use of number of days hospitalized as a proxy for clinical symptoms, which may not directly reflect levels of psychopathology, given the criteria for admission to hospital can vary depending on the health service.
A number of studies have identified trajectories based on clinical ratings of positive symptoms. Schennach et al. (2012) identified five response trajectories, where the majority of participants showed a moderate to good response (Schennach et al., 2012) while Case et al. (2010) identified four trajectories with over 80% of participants displaying a pattern of gradual improvement within the first three months of treatment (Case et al., 2010). The results from these studies were limited due to the very short follow-up period (12 weeks), given that schizophrenia is an illness manifested over several years. While these modern statistical techniques are generating new information about symptom trajectories in schizophrenia, further longitudinal studies using clinical data are required. Furthermore, there are no current studies that have examined negative symptom trajectories using clinical data and latent class analysis.
The aim of this study was to identify discrete trajectories for positive and negative symptoms using structured clinical assessments collected over a ten year period within a large representative sample of people with first episode psychosis. Additionally, the study identified which baseline characteristics discriminated between different trajectories.
Section snippets
Sample
A sample of 496 patients who received ICD-10 diagnosis of schizophrenia spectrum disorder diagnosis (F20–29) were recruited in the original OPUS trial (1998–2000). People with a schizotypal disorder (F21) were excluded, as the study was concerned with identifying symptom trajectories for people that had experienced psychotic symptoms at the time of inclusion. None of the participants recruited for the OPUS trial had received more than 12 weeks of anti-psychotic medication. The original OPUS
Results
The baseline characteristics of the sample (n = 496) are presented in Table 1. The majority of participants had a schizophrenia diagnosis (F20). Mean age was approximately 27 years at inclusion and a third of the sample had a substance abuse diagnosis at baseline. A total of 446 people participated at 1 year follow-up, 406 people participated at 2 year follow-up, 265 people participated at 5 year follow up and 304 people participated at 10 year follow-up. There were no significant differences between
Discussion
This study investigated long-term trajectories in first episode psychosis and continues the body of research that has examined the manifestation of psychopathology over time (Goghari et al., 2013, Harrow et al., 1997, Herbener and Harrow, 2001, Herbener and Harrow, 2004) using statistical techniques to identify symptom course based on longitudinal clinical data. Results indicate that the majority of participants experience a reduction and stabilization of positive symptoms over time while
Study limitations
As this study utilized a cohort from a randomized clinical trial, it is reasonable to assume that the two interventions impacted differentially on symptom trajectories within the first two years. The differences on primary outcomes (symptoms and functioning) between the two interventions had disappeared at 5 year follow-up. Results from the predictor analysis where treatment type was entered as a covariate, indicated that treatment type did not have a significant impact on any of positive
Clinical implications
The identification of different symptom trajectories and significant changes in symptom levels several years after diagnosis has important implications for the timing and length of interventions within first episode psychosis populations. People characterized with poor symptom trajectories could be targeted to receive extended intensive treatment or the provision of interventions at different times throughout the course of illness. These strategies could potentially improve long term outcomes.
Conclusion
This study identified distinct trajectories for both positive and negative symptoms, supporting a heterogeneous illness course. Further studies using structured clinical assessments over longer time periods are required to establish an evidence base regarding the trajectories for positive and negative psychopathology and to identify the factors that influence these trajectories. This knowledge could be used to inform future interventions that potentially could impact on illness course and
Clinical points
- •
Trajectories for positive and negative symptoms are heterogeneous among people with first episode psychosis.
- •
Positive symptoms showed a general pattern of reduction and stabilization while negative symptoms show less change over a 10 year period.
- •
Significant changes in symptoms can occur many years after diagnosis and have implications for the prognosis and timing of interventions within first episode psychosis.
Role of funding source
The study was funded by unconditional grants from Lundbeck, Tryg Foundation and region Mid-Jylland's research fund for psychiatric research. The sponsors had no influence on the design, conduct or reporting of results in this study.
Contributors
MN, OM and SFA conceived the study. MN rose the funding. SFA drafted the first manuscript. EBJ conducted the analysis and EBJ, MN, SFA, and CRH were involved in the interpretation of results. All authors critically revised the manuscript and approved the version submitted for publication.
Conflict of interest
All authors declare they have no conflict of interest.
Acknowledgments
The authors wish to thank Heidi Jensen (BSc) and Lars Morså (MSc) from Mental Health Centre Copenhagen, and Lars Morså (MSc) from Centre for Psychiatric Research, Aarhus University, Denmark who were involved in the data collection at 10 year follow-up.
References (75)
- et al.
Prediction of a single psychotic episode: a 7.5-year, prospective study in first-episode psychosis
Schizophr. Res.
(2011) - et al.
Predictors of recovery in first episode psychosis: the OPUS cohort at 10 year follow-up
Schizophr. Res.
(2013) - et al.
Duration of untreated psychosis and negative symptoms — a systematic review and meta-analysis of individual patient data
Schizophr. Res.
(Dec 2012) - et al.
Psychosocial treatments for negative symptoms in schizophrenia: current practices and future directions
Clin. Psychol. Rev.
(2013) - et al.
IRAOS: an instrument for the assessment of onset and early course of schizophrenia
Schizophr. Res.
(1992) - et al.
The relationship between duration of untreated psychosis and outcome: an eight-year prospective study
Schizophr. Res.
(2005) - et al.
Elaboration on the early-onset hypothesis of antipsychotic drug action: treatment response trajectories
Biol. Psychiatry
(2010) - et al.
Trajectories of the course of schizophrenia: from progressive deterioration to amelioration over three decades
Schizophr. Res.
(2011) - et al.
Psychosocial and neuropsychiatric predictors of subjective recovery from psychosis
Psychiatry Res.
(2013) - et al.
Relationships among measures of treatment outcome in depressed patients
J. Affect. Disord.
(2003)
Generalizability studies of the Global Assessment of Functioning — Split version
Compr. Psychiatry
Self-efficacy and psychosocial functioning in schizophrenia: a mediational analysis
Schizophr. Res.
The course of schizophrenia: progressive deterioration, amelioration or both?
Schizophr. Res.
Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data
Schizophr. Res.
Application of pharmacogenetics to psychotic disorders: the first consensus conference. The Consensus Group for Outcome Measures in Psychoses for Pharmacological Studies
Schizophr. Res.
Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia
Prog. Neuropsychopharmacol. Biol. Psychiatry
The relation between objective and subjective domains of recovery among persons with schizophrenia-related disorders
Schizophr. Res.
Response trajectories in “real-world” naturalistically treated schizophrenia patients
Schizophr. Res.
A scientific agenda for the concept of recovery as it applies to schizophrenia
Clin. Psychol. Rev.
Negative symptoms and depression predict lower psychological well-being in individuals with schizophrenia
Compr. Psychiatry
Schizophrenia
Lancet
Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients
Schizophr. Res.
An industry perspective on the NIMH consensus statement on negative symptoms
Schizophr. Bull.
Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years
Psychol. Med.
Diagnostic and Statistical Manual of Mental Disorder
Positive and negative symptoms in schizophrenia. A critical reappraisal
Arch. Gen. Psychiatry
Remission in schizophrenia: proposed criteria and rationale for consensus
Am. J. Psychiatry
Recovery from mental illness: the guiding vision of the mental health service system in the 1990's
J. Psychosocial Rehabil.
A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change
Arch. Gen. Psychiatry
On the methods and theory of reliability
J. Nerv. Ment. Dis.
Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial
Arch. Gen. Psychiatry
A latent-class mixture model for incomplete longitudinal Gaussian data
Biometrics
Early intervention in psychosis. The critical period hypothesis
Br. J. Psychiatry Suppl.
Persistent negative symptoms in schizophrenia: an overview
Schizophr. Bull.
Measurement of premorbid adjustment in chronic schizophrenia
Schizophr. Bull.
The heterogeneity of antipsychotic response in the treatment of schizophrenia
Psychol. Med.
The role of subjective illness beliefs and attitude toward recovery within the relationship of insight and depressive symptoms among people with schizophrenia spectrum disorders
J. Clin. Psychol.
Cited by (132)
Time is the enemy: Negative symptoms are related to even slight differences in the duration of untreated psychosis
2024, Comprehensive Psychiatry